Gelteq Ltd
Close on Oct 19, 2026
About Gelteq
Pharmaceutical Preparations, SIC 2834
Gelteq Limited is an Australian clinical and consumer product company that develops and commercializes edible gels and gel-based dosage forms. The company designs gel formulations for multiple vertical markets, offering products across categories ranging from food-grade supplements to pharmaceutical applications that incorporate active pharmaceutical ingredients. Gelteq supplies its products and delivery technologies to corporate partners, commercial distributors, and end consumers across health, sports supplement, and therapeutic areas.
The company conducts business internationally with operations and corporate entities situated in Australia and the United States, alongside business activities in the People's Republic of China. Gelteq relies on third-party manufacturing networks, raw material suppliers, and specialized external partners to produce, distribute, and market its products. The company maintains its principal executive offices and global headquarters in South Yarra, Victoria, Australia.
Summary of the business section of Gelteq's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Gelteq Ltd
- Founded
- 2018
- Headquarters
- South Melbourne Vic, Australia
- Address
- Level 4, 100 Albert Road
- Phone
- 61390873990
- Website
- gelteq.com
- Industry
- Pharmaceutical Preparations
- Incorporated in
- C3
- Fiscal year ends
- June 30
- Auditor
- M&K CPAS, PLLC, Woodlands, TX
Stock & identifiers
- Ticker
- GELS
- Exchange
- Nasdaq
- IPO date
- Oct 29, 2024
- Shares outstanding
- 11M, Nov 13, 2024
- Filer category
- Non-accelerated filer<br>Emerging growth company
- SEC CIK
- 1920092
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Paul Michael WYNNE | Chief Scientific Officer | – |
| Bradley Glenn Karp | Head of Sales and Marketing | 500,000 |
| Nathan J. Givoni | Chief Executive Officer | 657,087 |
| Simon H. Szewach | Director | 338,197 |
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Nov 3, 2025 | Late filing | Notification of late filing |
| Oct 31, 2024 | Late filing | Notification of late filing |
| Oct 17, 2024 | Listing | Registration of securities on an exchange (Form 8-A) |
| Mar 31, 2022 | Name change | Name changed from Gelteq Pty Ltd. to Gelteq Ltd |